• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

ASH Releases Analysis on Impact of Medicare Proposed Rules on Hematologists

Article

On July 8, 2012, the Centers for Medicare & Medicaid Services (CMS) released two major Medicare proposed rules impacting payment for physician and hospital outpatient services in 2014. ASH will submit comments to CMS on the proposed rules by the September 6 deadline and would like to incorporate feedback from the Society's practice-based members.

On July 8, 2012, the Centers for Medicare & Medicaid Services (CMS) released two major Medicare proposed rules impacting payment for physician and hospital outpatient services in 2014. ASH will submit comments to CMS on the proposed rules by the September 6 deadline and would like to incorporate feedback from the Society's practice-based members. Review ASH's detailed analysis of the key issues and potential impact that the proposed rules will have on hematology and please contact ASH Government Relations and Practice Manager Stephanie Kaplan by August 16 with any comments you have about the proposed rule.

ASH Analysis of the Proposed Medicare Physician Fee Schedule (MPFS) CMS is proposing several changes to the physician fee schedule that will result in a net overall reduction in payment of 1 percent for hematology-oncology services. Modest changes are proposed for office-based evaluation and management (E/M) services while hospital visit and critical care codes will see increases of about 3 percent. Reductions are proposed for infusion codes, bone marrow biopsy and aspiration procedures. As in past years, the MPFS rule does not address the Sustainable Growth Rate formula driven payment reductions that will occur unless Congress takes action before the end of the year.

Read the full story here: http://bit.ly/17owDI6

Source: ASH

Related Videos
Carrie Kozlowski
Carrie Kozlowski, OT, MBA
Carrie Kozlowski, OT, MBA
kimberly westrich
Bruce Sherman, MD
Dr Jeffrey Sippel
Lalan Wilfongd, MD, US Oncology Network
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.